Osaic Holdings’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-25
Closed -$125 7445
2024
Q1
$125 Buy
+25
New +$24 ﹤0.01% 7019
2023
Q4
Sell
-30
Closed -$300 7335
2023
Q3
$300 Sell
30
-20
-40% -$57 ﹤0.01% 7082
2023
Q2
$3.25K Buy
50
+35
+233% +$111 ﹤0.01% 6487
2023
Q1
$900 Buy
+15
New +$45 ﹤0.01% 6988

Other funds holding CTSO

Osaic Holdings's CTSO Position: Q1 2026 in Review

Osaic Holdings held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 130,419 shares worth $74.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4902.

Osaic Holdings first reported a position in CTSO in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.54M in Q1 2022. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • Osaic Holdings held 130,419 shares of Cytosorbents Corp worth $74.2K as of Q1 2026.
  • Osaic Holdings left its Cytosorbents Corp share count unchanged in Q1 2026.
  • Cytosorbents Corp made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4902 holding.
  • Osaic Holdings first reported a position in Cytosorbents Corp in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Cytosorbents Corp position peaked at $1.54M in Q1 2022.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.